Submitted by elizabethwu1 on Tue, 08/23/2016 - 2:45pm NCT02760602 Solanezumab United States Wednesday, June 1, 2016 – Tuesday, May 30, 2017 26 Phase 3 Alzheimer's Disease Tuesday, May 23, 2017 Eli Lilly & Co. Comments No Available Comments Make a Comment To make a comment you must login or register.
Submitted by elizabethwu1 on
Submitted by elizabethwu1 on
Comments
No Available Comments
Make a Comment
To make a comment you must login or register.